Hypofractionated Proton Therapy with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Trial from the University of Florida and Proton Collaborative Group
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 107 (3), 455-461
- https://doi.org/10.1016/j.ijrobp.2020.03.015
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trialThe Lancet Oncology, 2019
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLCThe New England Journal of Medicine, 2018
- Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance)International Journal of Radiation Oncology*Biology*Physics, 2018
- Thoracic Radiation Normal Tissue InjurySeminars in Radiation Oncology, 2017
- Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small Cell Lung CancerJAMA Oncology, 2017
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 studyThe Lancet Oncology, 2015
- Dose-Limiting Toxicity After Hypofractionated Dose-Escalated Radiotherapy in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2013
- Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung CarcinomaJournal of Thoracic Oncology, 2012
- Protons Safely Allow Coverage of High-Risk Nodes for Patients with Regionally Advanced Non-Small-Cell Lung CancerTechnology in Cancer Research & Treatment, 2011
- Pilot Study of Accelerated Radiotherapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung CancerSeminars in Oncology, 2005